HÔPITAL EUROPÉEN GEORGE POMPIDOU

PARIS 14 trials 2 recruiting

14 Registered trials

2 Currently recruiting

Organisation

HÔPITAL EUROPÉEN GEORGE POMPIDOU

Location

PARIS, France

Identifier

ORL-000002936

Address

20 rue Leblanc, 75015, France

Departments

Cancérologie médicale
cardiology
Functional Ophthalmology Unit
gastro enterology
Gastroenterology Oncology
Medical Oncology
Nephrology
ONCOLOGIE
ONCOLOGIE MEDICALE
Oncology
Service de Cancérologie Médicale

Clinical trials at this site (14)

Search interface

A trial to learn how safe durvalumab with chemotherapy is and how well it works in adults with muscle-invasive bladder cancer Pending

2024-519246-75-01 Patients With Muscle-Invasive Bladder Cancer 4
PRODIGE 90 - FFCD 22024 - PREDIR-NEOREC - Neoadjuvant dostarlimab with short course radiotherapy in a watch-and-wait strategy for microsatel… Recruiting

2024-510772-20-00 Rectal cancer locally advanced with microsatellite unst 4 2025-02-06
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
Management of Anticoagulant Therapy monitored by an implantable device with telecardiology in patients with Acute Coronary Syndrome associat… Ended

2024-515433-15-02 acute coronary syndrome 6 2025-01-29
PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed… Ended

2023-505972-32-00 locally advanced anal squamous cell carcinoma 5 2024-02-26
Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus Dostarlimab in first line advanc… Ended

2023-510097-14-00 Patients with MMR deficient relapse or advanced / metas 5 2022-04-15
An open-label phase 1b/2 study assessing the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic… Ended

2024-514905-79-00 Metastatic pancreatic ductal adenocarcinoma 9 2021-09-17
TALAPRO 2: A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT… Ended

2023-509087-20-00 Metastatic Castration-resistant Prostate Cancer 5 2019-04-16
Randomized phase 2 trial of two chemotherapy regimens plus or minus bevacizumab in patients with well differentiated pancreatic neuroendocri… Ended

2023-505286-84-00 Pancreatic well differentiated neuroendocrine tumors (N 4 2018-06-25
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, … Ended

2024-512470-10-00 End-stage Renal disease 11 2018-02-02
A phase I of TG6050 in the treatment of patients with metastatic lung cancer Ended

2024-513093-22-00 Non-small cell lung cancer (NSCLC) 1 2023-03-27
First-in-human phase I/IIa study investigating inhaled CIS-DPI as add-on treatment in Stage IV NSCLC patients Ended

2022-501183-17-00 Non-Small Cell Lung Cancer 7 2023-02-23
AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syn… Ended

2024-514896-17-00 Wolfram syndrom 4 2021-10-08
Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oe… Ended

2024-515221-29-00 Locally advanced or metastatic oesogastric adenocarcino 10 2016-12-19